companydata.dkcompanydata.dk

VIPERGEN R & D III K/S: Financial statements 2015

CVR: 30355644

Source: annual report 2015, Danish Business Authority

01/01/2015 – 31/12/2015

VIPERGEN R & D III K/S (CVR 30355644) has filed annual accounts for 2015. In 2015, the company reported a net result of DKK -932,000 compared with DKK -12,291,000 the year before. Equity in the 2015 report amounted to DKK 0.

Revenue
DKK 0
Profit/Loss
DKK -932,000
Equity
DKK 0
Total Assets
DKK 2,835,000

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
20150--932K0-
2014805K--12.3M932K-
2013804K--10.7M-1.8M-
20120--10.2M8.9M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is VIPERGEN R & D III K/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2015

VIPERGEN R & D III K/S: The 2014 annual report is outJun 12, 2015

VIPERGEN R & D III K/S has published its annual report for 2014. Revenue came to DKK 805,000, and the net result was DKK -12,291,000.

Gunnar Kjems joins VIPERGEN R & D III K/S as chairmanJun 11, 2015

As of June 11, 2015, Gunnar Kjems is registered as chairman of VIPERGEN R & D III K/S.

Eigil Bjerl Nielsen steps down as chairman of VIPERGEN R & D III K/SJun 11, 2015

As of June 11, 2015, Eigil Bjerl Nielsen has stepped down as chairman of VIPERGEN R & D III K/S.

Gunnar Kjems leaves the board of VIPERGEN R & D III K/SJun 10, 2015

As of June 10, 2015, Gunnar Kjems has left the board of directors of VIPERGEN R & D III K/S.

VIPERGEN R & D III K/S appoints new auditorJun 9, 2015

As of June 9, 2015, KPMG P/S has been appointed auditor of VIPERGEN R & D III K/S.

Auditor steps down at VIPERGEN R & D III K/SJun 9, 2015

As of June 9, 2015, EY Godkendt Revisionspartnerselskab has stepped down as auditor of VIPERGEN R & D III K/S.

About VIPERGEN R & D III K/S

VIPERGEN R & D III K/S was a Danish company of the type Kommanditselskab based in København V, founded in 2007. The company has been dissolved on 31 May 2019. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. In 2018, the company reported a gross profit of DKK -10,000 and a net result of DKK -7,000 compared with DKK 211,000 the year before. Equity in the 2018 report amounted to DKK 152,000.

Source: annual report 2018, Danish Business Authority

Other financial years